KALLI SASSAMAN: Open Payments
NPI 1538948484 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,843 in 116 payments from 22 companies in 2025. Trend: 2023 $142 · 2024 $1,791 · 2025 $1,843
Food & beverage: $1,843
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $440 |
| AstraZeneca Pharmaceuticals LP | 10 | $172 |
| Axsome Therapeutics, Inc. | 7 | $153 |
| Lundbeck LLC | 11 | $144 |
| Amgen Inc. | 10 | $140 |
| Dexcom, Inc. | 10 | $137 |
| Antares Pharma, Inc. | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
Products named: REXULTI, QULIPTA, Auvelity, Dexcom G6 Transmitter, XYOSTED, TRINTELLIX, BOTOX, VRAYLAR.
Industry payments across AR — which companies pay providers there.
